Stephenson Cancer Center Affiliates with Sarah Cannon Research Institute to Expand Its Oncology Early-Phase Clinical Trials Program

The University of Oklahoma announced today that the Stephenson Cancer Center has affiliated with the Sarah Cannon Research Institute, one of the nation’s largest clinical trials and research management programs. This affiliation, the first academic affiliation for the Tennessee-based institute, will provide the Stephenson Cancer Center with access to the Institute's large portfolio of early-phase oncology clinical trials. By participating in clinical trials research, especially early-phase or “phase I” clinical trials, cancer patients can gain first access to new cancer drugs.

Read more >